U.S. Markets open in 3 hrs 10 mins

Ligand Pharmaceuticals Inc (LGND) CEO John L Higgins Bought $283,750 of Shares

- By insider

CEO of Ligand Pharmaceuticals Inc (LGND) John L Higgins bought 2,500 shares of LGND on 05/14/2019 at an average price of $113.5 a share. The total cost of this purchase was $283,750.

Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand Pharmaceuticals Inc has a market cap of $2.21 billion; its shares were traded at around $112.60 with a P/E ratio of 3.19 and P/S ratio of 11.02. Ligand Pharmaceuticals Inc had annual average EBITDA growth of 57.40% over the past five years.


CEO Recent Trades:

  • CEO John L Higgins bought 2,500 shares of LGND stock on 05/14/2019 at the average price of $113.5. The price of the stock has decreased by 0.79% since.

Directors and Officers Recent Trades:

  • Director John W Kozarich sold 2,500 shares of LGND stock on 05/14/2019 at the average price of $112.92. The price of the stock has decreased by 0.28% since.

For the complete insider trading history of LGND, click here

.This article first appeared on GuruFocus.